In addition, Vendrell et al. revealed that reduced expression of ESR1 was associated with tamoxifen failure, disease relapse, and shorter overall survival (OS) in ER-positive breast tumor samples [23]. This evidence concerns the gene ESR1 and breast neoplasm.